The initial results of a Phase III clinical trial in India for a low-cost drug to cure a deadly parasitic disease will be presented by Victoria Hale, Ph.D., founder and CEO of the Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S. The results will be made at the American Society of Tropical Medicine and Hygiene conference to be held Nov. 7-11 at the Fontainebleau Hilton Resort in Miami. Executives from OneWorld Health will also appear on numerous panels at the conference. The company will be represented at booth 16.

SCHEDULE OF EVENTS
Monday, Nov. 8

• Victoria Hale, Ph.D., will chair a panel, "New Approaches to Effective, Affordable Treatment and Prevention of Pediatric Diarrhea in the Developing World."
  • 10:15a 12:30p, Brittany/Champagne

• Victoria Hale, Ph.D., will deliver an oral presentation, "Paromomycin as a New Cure for Visceral Leishmaniasis: Initial Results of a Phase III Multicenter, Randomized, Controlled, Clinical Trial to Assess Safety and Efficacy."
  • 1:45p 2:00p, LeMans/Bordeaux/Burgundy

Tuesday, Nov. 9


• Poster session A, "Paromomycin as a New Cure for Visceral Leishmaniasis: Initial Results of a Phase III Multicenter, Randomized, Controlled, Clinical Trial to Assess Safety and Efficacy."
  • 12:05p 1:30p, Fontainebleau CD

Wednesday, Nov. 10


• Ahvie Herskowitz, M.D., Chief Operating Officer, will discuss "Pediatric Analysis of Paromomycin for Visceral Leishmaniasis" on a panel, "Progress in Developing Novel Global Health Products."
  • 2:30p 4:20p, Fontainebleau B

Thursday, Nov. 11


• Victoria Hale, Ph.D., will discuss "The New Role for Nonprofits in Facilitating Drug Development for Tropical Diseases" as part of "New Drugs for Parasitic Diseases: Meeting the Challenge."
  • 8:00a 9:50a, Fontainebleau C

'"/>

Contact: Joanne Hasegawa
jhasegawa@oneworldhealth.org
415-421-4700
Institute for OneWorld Health
1-Nov-2004

Page: 1
Related biology news :

1. OneWorld Health selects Odyssey Research for phase 4 study in India
2. Institute for OneWorld Health hosts global health seminar at AAAS Annual Meeting
3. Institute for OneWorld Health awarded $46 million grant to combat diarrheal disease
4. Institute for OneWorld Health hosts panels at ASTMH
5. Institute for OneWorld Health to exhibit at BIO
6. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
7. OneWorld Health awarded Sapling Foundation grant
8. OneWorld Health receives multimillion dollar grant for next steps in control of deadly disease
9. Institute for OneWorld Health CEO speaks at 2005 World Life Sciences Forum, BioVision
10. Institute for OneWorld Health awarded Skoll Foundations Social Entrepreneurship Award
11. OneWorld Health named business leader in public health on 2004 Scientific American 50